AGP Executive Report
Last update: 12 hours agoWeight-loss breakthrough in the UAE: The UAE has approved oral Wegovy (semaglutide) for long-term weight management and cardiovascular risk reduction, giving residents a non-injectable option—though doctors stress it’s not for everyone and requires medical assessment based on BMI and related conditions. Premium protection for UAE health insurance: Policybazaar.ae launched “Health Insurance Premium Lock,” letting selected plan holders in Dubai and the Northern Emirates freeze premiums for up to five years to reduce jumps from medical inflation and age-band loading. Ebola misinformation push: MoHAP urged residents to rely on official sources, debunking myths that Ebola spreads through the air or via ordinary travel contact, and reiterated that the WHO risk assessment is currently low. Abu Dhabi lab expansion: Yas Clinic unveiled a next-generation diagnostic laboratory in Abu Dhabi, aiming to improve patient-focused testing. Food reform for healthier UAE diets: Al Ain Farms Group pledged to cut added sugars by 10–20% across key dairy products (flavoured milk, yoghurt, laban) as part of Abu Dhabi’s Healthy Living Strategy. Community fitness momentum: Abu Dhabi Running Team has grown into a 4,000+ member wellness community focused on accessible training and injury prevention.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
![[Latest] Global CRISPR-based Gene Editing Market Size/Share Worth USD 12.6 Billion by 2034 at a 13.01% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)](https://ml.globenewswire.com/Resource/Download/731f39a7-430d-4183-b708-b1114902141b/legaltech-market-size-2024-to-2034-usd-billion-.png)
